Literature DB >> 18473402

Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.

Jia-Ding Mao1, Pei Wu, Ying-Lin Yang, Jian Wu, He Huang.   

Abstract

AIM: To explore the correlation between the mRNAs and protein expression of gastrin (GAS), somatostatin (SS) and apoptosis index (AI), apoptosis regulation gene Fas/FasL and caspases in large intestinal carcinoma (LIC).
METHODS: Expression of GAS and SS mRNAs were detected by nested RT-PCR in 79 cases of LIC. Cell apoptosis was detected by molecular biology in situ apoptosis detecting methods (TUNEL). Immunohistochemical staining for GAS, SS, Fas/FasL, caspase-3 and caspase-8 was performed according to the standard streptavidin-biotin-peroxidase (S-P) method.
RESULTS: There was a significant positive correlation between mRNA and protein expression of GAS and SS (GASrs = 0.99, P < 0.01; SSrs = 0.98, P < 0.01). There was significant difference in positive expression rates of GAS, SS mRNAs and protein among different histological differentiation, histological types and Dukes' stage of LIC. The AI in GAS high and moderate expression groups was significantly lower than that in low expression groups (3.75 +/- 2.38 vs 7.82 +/- 2.38, P < 0.01; 5.51 +/- 2.66 vs 7.82 +/- 2.38, P < 0.01), and the AI in SS high and moderate expression groups was significantly higher than that in low expression groups (9.03 +/- 1.76 vs 5.35 +/- 3.00, P < 0.01; 7.44 +/- 2.67 vs 5.35 +/- 3.00, P < 0.01). There was a significant negative correlation between the integral ratio of GAS to SS and the AI (r(s) = -0.41, P < 0.01). The positive expression rate of FasL in GAS high and moderate expression groups was higher than that in low expression group (90.9% and 81.0% vs 53.2%, P < 0.05). The positive expression rates of Fas, caspase-8 and caspase-3 in SS high (90.0%, 90.0% and 100%) and moderate (80.0%, 70.0%, 75.0%) expression groups were higher than that in low expression group (53.1%, 42.9%, 49.0%) (90.0% and 80.0% vs 53.1%, P < 0.05; 90.0% and 70.0% vs 42.9%, P < 0.05; 100.0% and 75.0% vs 49.0%, P < 0.05). There was a significant positive correlation between the integral ratio of GAS to SS and the semiquantitative integral of FasL (rs = 0.32, P < 0.01).
CONCLUSION: GAS and SS play important roles in the regulation and control of cell apoptosis in LIC, and the mechanism may be directly related to the aberrant expression of Fas/FasL. The GAS and SS will be valuable targets of the biological behavior of LIC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473402      PMCID: PMC2710719          DOI: 10.3748/wjg.14.2802

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  51 in total

1.  [Expression of gastrin, somatostatin, PCNA and Fas-L in the mucosa of gastric antrum of children with chronic gastritis and duodenal ulcer].

Authors:  Xiao-zhi Xie; Zong-min Wang; Hai-yan Zhang; Lan Wang; Bao-hui Gao; Xue-mei Li; Wei-guo Hu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2006-10

2.  Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer.

Authors:  Martha L Slattery; Carol Sweeney; Maureen Murtaugh; Khe Ni Ma; Roger K Wolff; John D Potter; Bette J Caan; Wade Samowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

3.  Correlation between expression of gastrin, somatostatin and cell apoptosis regulation gene bcl-2/bax in large intestine carcinoma.

Authors:  Jia-Ding Mao; Pei Wu; Xiang-Hou Xia; Ji-Qun Hu; Wen-Bin Huang; Guo-Qiang Xu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

6.  ras p21 expression in the progression of breast cancer.

Authors:  F B Fromowitz; M V Viola; S Chao; S Oravez; Y Mishriki; G Finkel; R Grimson; J Lundy
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

Review 7.  Dynamics of colorectal cancer.

Authors:  Franziska Michor; Yoh Iwasa; Christoph Lengauer; Martin A Nowak
Journal:  Semin Cancer Biol       Date:  2005-12       Impact factor: 15.707

Review 8.  Somatostatin: a hormone for the heart?

Authors:  Amy C Badway; Allan D Blake
Journal:  Curr Vasc Pharmacol       Date:  2005-04       Impact factor: 2.719

Review 9.  New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

Authors:  A V Schally; K Szepeshazi; A Nagy; A M Comaru-Schally; G Halmos
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

10.  Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.

Authors:  Astrid Capello; Eric P Krenning; Bert F Bernard; Wout A P Breeman; Martin P van Hagen; Marion de Jong
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

View more
  1 in total

1.  Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma.

Authors:  Jia-Ding Mao; Pei Wu; Jian-Xiong Huang; Jian Wu; Guang Yang
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.